1. Reconditioned monocytes are immunomodulatory and regulate inflammatory environment in sepsis.
- Author
-
Jain, Kshama, Mohan, K. Varsha, Roy, Gargi, Sinha, Prakriti, Jayaraman, Vignesh, Kiran, Yadav, Ajit Singh, Phasalkar, Akshay, Deepanshu, Pokhrel, Anupa, Perumal, Nagarajan, Sinha, Nitin, Chaudhary, Kiran, and Upadhyay, Pramod
- Subjects
- *
MONONUCLEAR leukocytes , *SEPSIS , *MONOCYTES , *LEUCOCYTES , *MESENCHYMAL stem cells - Abstract
Sepsis is caused by dysregulated immune response to severe infection and hyper inflammation plays a central role in worsening the disease. The immunomodulatory properties of mesenchymal stem cells (MSCs) have been evaluated as a therapeutic candidate for sepsis. Reconditioned monocytes (RM), generated from healthy human peripheral blood mononuclear cells (PBMCs) exhibit both macrophage and MSCs-like properties. RM were administered at different stages of sepsis in a mouse model. It reduced serum levels of IL6, MCP-1, IL-10, improved hypothermia, increased survival, and recovery from 0 to 66% when combined with antibiotics in the mouse model. The reduced human leucocyte antigen DR molecules expression on RM enables their co-culture with PBMCs of sepsis patients which resulted in reduced ROS production, and up-regulated TGF-β while down-regulating IL6, IL8, and IL-10 in-vitro. RM are potentially immunomodulatory, enhance survival in sepsis mouse model and modulate inflammatory behaviour of sepsis patient's PBMCs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF